RxDoctor Payments Data

Tiffany Ly, PA

Physician Assistant · Litchfield Park, AZNPI 1891204772

Payments from drug & device makers

$3,111in general payments, 2019–2025

Across 126 payments — averaging $24.69 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Astellas Pharma US Inc$621
  • Coloplast$420
  • Endo Pharmaceuticals Inc.$227
  • Pfizer$173
  • AbbVie$165
  • Myriad Genetic Laboratories, Inc.$165
  • plus $1K from 26 others

What the payments were for

  • Food & beverage$2,81290%
  • Education$29910%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$3,111 in reported general payments places this provider in the 85th percentile of 2,888 physician assistant providers in Arizona.

See all physician assistant providers in Arizona

Medicare billing

Part B allowed, 2024
$37,750
Medicare patients
241
Services billed
480

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
MyrbetriqMirabegron74$63,869
Tamsulosin Hcl177$2,814
Trospium Chloride31$2,646
Finasteride103$1,740
Cephalexin54$928
Solifenacin Succinate23$883
Methenamine Hippurate19$876
Alfuzosin Hcl ErAlfuzosin Hcl23$648
Ciprofloxacin Hcl159$492
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen73$276
Oxybutynin Chloride24$162
Clotrimazole-BetamethasoneClotrimazole/Betamethasone Dip15$161
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav17$157
Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim15$84
Tramadol Hcl13$20

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Astellas Pharma US IncMyrbetriq$621$63,86974 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 2,888 physician assistant providers in Arizona.

Other physician assistant in Litchfield Park

See the full list for Arizona

Where these figures come from

Is this you, or does something look wrong? →